Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,413 | 37,107 | 135,774 | 81,462 | 186,980 |
| Marketable Securities | 59,541 | 19,942 | N/A | 44,480 | 3,918 |
| Other current assets | 4,908 | 5,092 | 5,310 | 7,603 | 13,526 |
| TOTAL | $82,862 | $62,141 | $141,084 | $133,545 | $204,424 |
| Non-Current Assets | |||||
| PPE Net | 1,867 | 2,362 | 3,259 | 4,816 | 6,180 |
| Investments And Advances | 0 | 0 | 0 | 0 | 15,110 |
| Other Non-Current Assets | 3,804 | 5,591 | 7,184 | 8,332 | 9,655 |
| TOTAL | $5,671 | $7,953 | $10,443 | $13,148 | $30,945 |
| Total Assets | $88,533 | $70,094 | $151,527 | $146,693 | $235,369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,982 | 2,571 | 2,517 | 4,737 | 3,015 |
| Accrued Expenses | 13,526 | 15,557 | 16,842 | 16,039 | 25,394 |
| TOTAL | $21,233 | $21,737 | $23,906 | $33,129 | $38,957 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 151 | 1,308 | 9,210 | 7,641 |
| Other Non-Current Liabilities | 13,755 | 77,208 | 35,310 | 9,201 | 11,420 |
| TOTAL | $13,755 | $77,330 | $35,541 | $9,664 | $11,681 |
| Total Liabilities | $34,988 | $99,067 | $59,447 | $42,793 | $50,638 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,188 | 6,114 | 3,027 | 1,718 | 1,708 |
| Common Shares | 9 | 8 | 7 | 4 | 4 |
| Retained earnings | -642,201 | -618,008 | -486,797 | -399,118 | -303,072 |
| Other shareholders' equity | 468 | 451 | 545 | 401 | 452 |
| TOTAL | $53,545 | $-28,973 | $92,080 | $103,900 | $184,731 |
| Total Liabilities And Equity | $88,533 | $70,094 | $151,527 | $146,693 | $235,369 |